INDiGO® is the new accelerated drug development service launched by Evotec; the new solution aims to reduce the time and cost of pre-clinical drug development whilst delivering a high-quality data package for CTA/IND level regulatory filings. Typical activities managed by the platform include API manufacture, formulation development, clinical supply, safety assessment, DMPK, bioanalysis and biomarkers, and regulatory submission documents preparation

LEAVE A REPLY

Please enter your comment!
Please enter your name here